Clinical Trials Logo

Active Rheumatoid Arthritis; Rheumatoid Arthritis clinical trials

View clinical trials related to Active Rheumatoid Arthritis; Rheumatoid Arthritis.

Filter by:
  • None
  • Page 1

NCT ID: NCT01480388 Withdrawn - Clinical trials for Active Rheumatoid Arthritis; Rheumatoid Arthritis

A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate

Start date: December 2011
Phase: Phase 2
Study type: Interventional

The purpose of the study is to assess the efficacy, safety and tolerability of JNJ-39758979 at doses of 10, 30, 100, and 300 mg/day compared with placebo (inactive medical substance) in patients with active rheumatoid arthritis despite concomitant treatment with methotrexate (MTX).